Lataa...
New horizon for radical cure of chronic hepatitis B virus infection
About 250 to 350 million people worldwide are chronically infected with hepatitis B virus (HBV), and about 700000 patients per year die of HBV-related cirrhosis or hepatocellular carcinoma (HCC). Several anti-viral agents, such as interferon and nucleos(t)ide analogues (NAs), have been used to treat...
Tallennettuna:
| Julkaisussa: | World J Hepatol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4958696/ https://ncbi.nlm.nih.gov/pubmed/27478536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v8.i21.863 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|